Clinical Trials Browser

Advanced Non-small Cell Lung Cancer × paclitaxel poliglumex × Clear all

NCT00487669 2014-01-09

Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 2 Completed

14 enrolled 8 charts

Advanced Non-small Cell Lung Cancer